InfuSystem Holdings, Inc. (INFU)
USD 8.26
(-8.93%)
USD 8.26
(-8.93%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 57.58 Million USD | 12.06% |
| 2022 | 51.38 Million USD | 4.2% |
| 2021 | 49.31 Million USD | -12.31% |
| 2020 | 56.23 Million USD | -1.14% |
| 2019 | 56.89 Million USD | 30.39% |
| 2018 | 43.63 Million USD | 15.04% |
| 2017 | 37.92 Million USD | -16.92% |
| 2016 | 45.65 Million USD | 1.07% |
| 2015 | 45.17 Million USD | 33.8% |
| 2014 | 33.76 Million USD | -2.57% |
| 2013 | 34.65 Million USD | -7.62% |
| 2012 | 37.51 Million USD | 3.91% |
| 2011 | 36.09 Million USD | -20.17% |
| 2010 | 45.22 Million USD | 36.11% |
| 2009 | 33.22 Million USD | -8.08% |
| 2008 | 36.14 Million USD | -24.17% |
| 2007 | 47.66 Million USD | 35.6% |
| 2006 | 35.15 Million USD | 19532.09% |
| 2005 | 179.05 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 52.57 Million USD | -8.7% |
| 2024 Q2 | 55.04 Million USD | 4.69% |
| 2023 Q4 | 57.58 Million USD | 13.8% |
| 2023 FY | 57.58 Million USD | 12.06% |
| 2023 Q1 | 54 Million USD | 5.09% |
| 2023 Q2 | 52.79 Million USD | -2.24% |
| 2023 Q3 | 50.6 Million USD | -4.15% |
| 2022 FY | 51.38 Million USD | 4.2% |
| 2022 Q4 | 51.38 Million USD | 0.41% |
| 2022 Q2 | 52.32 Million USD | 0.26% |
| 2022 Q3 | 51.17 Million USD | -2.19% |
| 2022 Q1 | 52.18 Million USD | 5.82% |
| 2021 Q4 | 49.31 Million USD | 2.03% |
| 2021 FY | 49.31 Million USD | -12.31% |
| 2021 Q2 | 51.29 Million USD | 7.68% |
| 2021 Q1 | 47.63 Million USD | -15.29% |
| 2021 Q3 | 48.33 Million USD | -5.78% |
| 2020 Q4 | 56.23 Million USD | 10.45% |
| 2020 Q1 | 60.65 Million USD | 6.62% |
| 2020 Q2 | 57.76 Million USD | -4.77% |
| 2020 Q3 | 50.91 Million USD | -11.85% |
| 2020 FY | 56.23 Million USD | -1.14% |
| 2019 Q4 | 56.89 Million USD | 1.27% |
| 2019 Q3 | 56.17 Million USD | 7.8% |
| 2019 Q2 | 52.1 Million USD | 9.7% |
| 2019 FY | 56.89 Million USD | 30.39% |
| 2019 Q1 | 47.5 Million USD | 8.87% |
| 2018 Q3 | 43.38 Million USD | 28.12% |
| 2018 Q1 | 33.73 Million USD | -11.06% |
| 2018 Q4 | 43.63 Million USD | 0.57% |
| 2018 FY | 43.63 Million USD | 15.04% |
| 2018 Q2 | 33.86 Million USD | 0.38% |
| 2017 FY | 37.92 Million USD | -16.92% |
| 2017 Q4 | 37.92 Million USD | 3.66% |
| 2017 Q3 | 36.58 Million USD | -8.55% |
| 2017 Q2 | 40.01 Million USD | -5.32% |
| 2017 Q1 | 42.25 Million USD | -7.44% |
| 2016 Q4 | 45.65 Million USD | -0.98% |
| 2016 FY | 45.65 Million USD | 1.07% |
| 2016 Q2 | 47.32 Million USD | -1.58% |
| 2016 Q3 | 46.1 Million USD | -2.57% |
| 2016 Q1 | 48.08 Million USD | 6.45% |
| 2015 Q3 | 44.77 Million USD | 1.15% |
| 2015 Q1 | 41.14 Million USD | 21.86% |
| 2015 FY | 45.17 Million USD | 33.8% |
| 2015 Q2 | 44.27 Million USD | 7.61% |
| 2015 Q4 | 45.17 Million USD | 0.88% |
| 2014 FY | 33.76 Million USD | -2.57% |
| 2014 Q2 | 33.37 Million USD | -4.1% |
| 2014 Q3 | 35.74 Million USD | 7.1% |
| 2014 Q4 | 33.76 Million USD | -5.54% |
| 2014 Q1 | 34.8 Million USD | 0.44% |
| 2013 FY | 34.65 Million USD | -7.62% |
| 2013 Q1 | 35.7 Million USD | -4.81% |
| 2013 Q4 | 34.65 Million USD | -0.35% |
| 2013 Q3 | 34.77 Million USD | -0.49% |
| 2013 Q2 | 34.94 Million USD | -2.13% |
| 2012 Q2 | 35.52 Million USD | -1.58% |
| 2012 Q3 | 34.68 Million USD | -2.35% |
| 2012 Q4 | 37.51 Million USD | 8.14% |
| 2012 FY | 37.51 Million USD | 3.91% |
| 2012 Q1 | 36.09 Million USD | -0.01% |
| 2011 Q3 | 38.77 Million USD | 6.48% |
| 2011 Q2 | 36.41 Million USD | -17.15% |
| 2011 Q1 | 43.95 Million USD | -2.81% |
| 2011 Q4 | 36.09 Million USD | -6.89% |
| 2011 FY | 36.09 Million USD | -20.17% |
| 2010 FY | 45.22 Million USD | 36.11% |
| 2010 Q4 | 45.22 Million USD | 0.94% |
| 2010 Q3 | 44.79 Million USD | -0.32% |
| 2010 Q1 | 31.3 Million USD | -5.78% |
| 2010 Q2 | 44.94 Million USD | 43.56% |
| 2009 Q4 | 33.22 Million USD | -0.92% |
| 2009 FY | 33.22 Million USD | -8.08% |
| 2009 Q3 | 33.53 Million USD | 4.0% |
| 2009 Q2 | 32.24 Million USD | -16.11% |
| 2009 Q1 | 38.43 Million USD | 6.34% |
| 2008 Q3 | 37.64 Million USD | -12.29% |
| 2008 Q2 | 42.91 Million USD | 1.5% |
| 2008 Q4 | 36.14 Million USD | -3.97% |
| 2008 Q1 | 42.27 Million USD | -11.3% |
| 2008 FY | 36.14 Million USD | -24.17% |
| 2007 Q3 | 38.84 Million USD | 5.06% |
| 2007 Q4 | 47.66 Million USD | 22.71% |
| 2007 FY | 47.66 Million USD | 35.6% |
| 2007 Q1 | 34.16 Million USD | -2.82% |
| 2007 Q2 | 36.97 Million USD | 8.23% |
| 2006 Q4 | 35.15 Million USD | 40.62% |
| 2006 Q3 | 24.99 Million USD | 346.1% |
| 2006 Q1 | 618.65 Thousand USD | 0.0% |
| 2006 Q2 | 5.6 Million USD | 805.79% |
| 2006 FY | 35.15 Million USD | 19532.09% |
| 2005 FY | 179.05 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Milestone Scientific Inc. | 3.35 Million USD | -1614.29% |
| Retractable Technologies, Inc. | 80.38 Million USD | 28.366% |
| Stereotaxis, Inc. | 19.98 Million USD | -188.073% |